2. Academic Validation
  3. Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy

Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy

  • Am J Hum Genet. 2014 Dec 4;95(6):708-20. doi: 10.1016/j.ajhg.2014.10.017.
Robert Kopajtich 1,  Thomas J Nicholls 2,  Joanna Rorbach 2,  Metodi D Metodiev 3,  Peter Freisinger 4,  Hanna Mandel 5,  Arnaud Vanlander 6,  Daniele Ghezzi 7,  Rosalba Carrozzo 8,  Robert W Taylor 9,  Klaus Marquard 10,  Kei Murayama 11,  Thomas Wieland 12,  Thomas Schwarzmayr 12,  Johannes A Mayr 13,  Sarah F Pearce 2,  Christopher A Powell 2,  Ann Saada 14,  Akira Ohtake 15,  Federica Invernizzi 7,  Eleonora Lamantea 7,  Ewen W Sommerville 9,  Angela Pyle 16,  Patrick F Chinnery 16,  Ellen Crushell 17,  Yasushi Okazaki 18,  Masakazu Kohda 19,  Yoshihito Kishita 20,  Yoshimi Tokuzawa 20,  Zahra Assouline 21,  Marlène Rio 21,  François Feillet 22,  Bénédict Mousson de Camaret 23,  Dominique Chretien 3,  Arnold Munnich 24,  Björn Menten 25,  Tom Sante 25,  Joél Smet 6,  Luc Régal 26,  Abraham Lorber 27,  Asaad Khoury 27,  Massimo Zeviani 28,  Tim M Strom 12,  Thomas Meitinger 29,  Enrico S Bertini 8,  Rudy Van Coster 6,  Thomas Klopstock 30,  Agnès Rötig 3,  Tobias B Haack 12,  Michal Minczuk 31,  Holger Prokisch 32
Affiliations

Affiliations

  • 1 Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • 2 MRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
  • 3 INSERM U1163, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, 75015 Paris, France.
  • 4 Department of Pediatrics, Klinikum Reutlingen, 72764 Reutlingen, Germany.
  • 5 Metabolic Unit, Children's Hospital, Ramban Health Care Campus, 31096 Haifa, Israel.
  • 6 Department of Pediatric Neurology and Metabolism, University Hospital Ghent, 9000 Ghent, Belgium.
  • 7 Unit of Molecular Neurogenetics, Fondazione IRCCS (Istituto di Ricovero e Cura a CarattereScientifico) Istituto Neurologico "Carlo Besta," 20126 Milan, Italy.
  • 8 Unità di Malattie Neuromuscolari e Neurodegenerative, Laboratorio di Medicina Molecolare, Dipartimento di Neuroscienze, IRCCS Ospedale Pediatrico Bambino Gesù, 00165 Roma, Italy.
  • 9 Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • 10 Department of Neuropediatrics, Klinikum Stuttgart, 70176 Stuttgart, Germany.
  • 11 Department of Metabolism, Chiba Children's Hospital, Chiba 266-0007, Japan.
  • 12 Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany.
  • 13 Department of Pediatrics, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
  • 14 Monique and Jacques Roboh Department of Genetic Research and the Department of Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, 91120 Jerusalem, Israel.
  • 15 Department of Pediatrics, Faculty of Medicine, Saitama Medical University, Saitama 350-0495, Japan.
  • 16 Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.
  • 17 Metabolic Paediatrician, National Centre for Inherited Metabolic Disorders, Temple Street Children's University Hospital, Dublin 1, Ireland.
  • 18 Department of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, Saitama 350-1241, Japan; Department of Functional Genomics & Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Saitama 350-1241, Japan.
  • 19 Department of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, Saitama 350-1241, Japan.
  • 20 Department of Functional Genomics & Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Saitama 350-1241, Japan.
  • 21 Departments of Pediatrics and Genetics, Hôpital Necker-Enfants Malades, 75015 Paris, France.
  • 22 Service de médecine infantile, Hôpitald'Enfants de Brabois, CHU de Nancy, 54511 Vandoeuvre-les Nancy, France.
  • 23 Service des Maladies Héréditaires du Métabolisme, CHU de Lyon, 69677 Bron, France.
  • 24 INSERM U1163, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, 75015 Paris, France; Departments of Pediatrics and Genetics, Hôpital Necker-Enfants Malades, 75015 Paris, France.
  • 25 Center for Medical Genetics, Ghent University, Ghent University Hospital, 9000 Ghent, Belgium.
  • 26 Department of Pediatrics, Metabolic Center, University Hospital Leuven, 3000 Leuven, Belgium.
  • 27 Department of Pediatric Cardiology, Ramban Medical Center, 31096 Haifa, Israel.
  • 28 MRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK; Unit of Molecular Neurogenetics, Fondazione IRCCS (Istituto di Ricovero e Cura a CarattereScientifico) Istituto Neurologico "Carlo Besta," 20126 Milan, Italy.
  • 29 Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich, 81675 Munich, Germany; Munich Heart Alliance, 80802 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany.
  • 30 Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany; German Research Center for Neurodegenerative Diseases (DZNE), 80336 Munich, Germany; Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, 80336 Munich, Germany.
  • 31 MRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK. Electronic address: [email protected].
  • 32 Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany. Electronic address: [email protected].
PMID: 25434004 DOI: 10.1016/j.ajhg.2014.10.017
Abstract

Respiratory chain deficiencies exhibit a wide variety of clinical phenotypes resulting from defective mitochondrial energy production through oxidative phosphorylation. These defects can be caused by either mutations in the mtDNA or mutations in nuclear genes coding for mitochondrial proteins. The underlying pathomechanisms can affect numerous pathways involved in mitochondrial physiology. By whole-exome and candidate gene sequencing, we identified 11 individuals from 9 families carrying compound heterozygous or homozygous mutations in GTPBP3, encoding the mitochondrial GTP-binding protein 3. Affected individuals from eight out of nine families presented with combined respiratory chain complex deficiencies in skeletal muscle. Mutations in GTPBP3 are associated with a severe mitochondrial translation defect, consistent with the predicted function of the protein in catalyzing the formation of 5-taurinomethyluridine (τm(5)U) in the anticodon wobble position of five mitochondrial tRNAs. All case subjects presented with lactic acidosis and nine developed hypertrophic cardiomyopathy. In contrast to individuals with mutations in MTO1, the protein product of which is predicted to participate in the generation of the same modification, most individuals with GTPBP3 mutations developed neurological symptoms and MRI involvement of thalamus, putamen, and brainstem resembling Leigh syndrome. Our study of a mitochondrial translation disorder points toward the importance of posttranscriptional modification of mitochondrial tRNAs for proper mitochondrial function.

Figures